Single Arm Phase II Trial of Nitroglycerin Plus Docetaxel in Elderly Untreated Stage IIIB/IV Non-small-cell Lung Cancer

Phase 2

• Conditions: on-small-cell lung cancer

• Registration Number: JPRN-UMIN000001820
• Lead Sponsor: Tohoku University Translational Research Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-03-31
• Study Completion: 2013-03-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Not provided

Exclusion Criteria

(a)No treatment with a vasodilator such as calcium channel blockers (b)No prior chemotherapy or radiotherapy; (c)Without uncontrollable brain metastasis; (d)No ischemic heart disease; (e)Without active interstitial pneumonitis (f)Without uncontrollable massive pleural effusion or pericardial effusion (g)Without pregnancy or nurse (h)No enrollment in another interventional study

Study & Design

• Study Type: Interventional
• Study Design: Not specified